InsideTrading SEC Form 4 insider trades

Stocks

OLMA Olema Pharmaceuticals, Inc.

Healthcare · Market cap: $661.5M

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $0, sold $60.9K 2022-Q2: bought $806.0K, sold $0 2022-Q3: bought $0, sold $0 2022-Q4: bought $0, sold $0 2023-Q1: bought $0, sold $0 2023-Q2: bought $0, sold $124.8K 2023-Q3: bought $19.8M, sold $972.4K 2023-Q4: bought $3.0M, sold $2.8M 2024-Q1: bought $0, sold $913.3K 2024-Q2: bought $0, sold $18.1M 2024-Q3: bought $0, sold $35.9M 2024-Q4: bought $4.7M, sold $11.4M 2025-Q1: bought $1.7M, sold $0 2025-Q2: bought $0, sold $0 2025-Q3: bought $0, sold $204.8K 2025-Q4: bought $0, sold $17.0M 2026-Q1: bought $0, sold $7.4M 2026-Q2: bought $0, sold $0 2026-Q3: bought $0, sold $291.2K 2026-Q4: bought $0, sold $0
Bought, above the line (largest quarter $19.8M) Sold, below the line (largest quarter $35.9M)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$0$60.9K
2022-Q2$806.0K$0
2022-Q3$0$0
2022-Q4$0$0
2023-Q1$0$0
2023-Q2$0$124.8K
2023-Q3$19.8M$972.4K
2023-Q4$3.0M$2.8M
2024-Q1$0$913.3K
2024-Q2$0$18.1M
2024-Q3$0$35.9M
2024-Q4$4.7M$11.4M
2025-Q1$1.7M$0
2025-Q2$0$0
2025-Q3$0$204.8K
2025-Q4$0$17.0M
2026-Q1$0$7.4M
2026-Q2$0$0
2026-Q3$0$291.2K
2026-Q4$0$0

Insider activity

Download CSV Up to 5,000 rows
Bought$37.1M8 buy days
Sold$95.5M77 sell days
Net insider flow-$58.4Mnet selling · 5 years
Latest trade2026-07-24Harmon Cyrus
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2026-07-24 Sell Harmon Cyrus Director 12,500 $11.71 $146.4K 1
2026-07-23 Sell Harmon Cyrus Director 12,500 $11.58 $144.7K 1
2026-03-04 Sell Mitchell Shawnte Other C-suite 25,000 $24.25 $606.4K 2
2026-03-03 Sell Mitchell Shawnte Other C-suite 15,000 $23.01 $345.2K 1
2026-01-20 Sell Harmon Cyrus Director 10,000 $26.88 $268.8K 1
2026-01-15 Sell Kovacs Shane William Charles Other officer 100,000 $28.73 $2.9M 1
2026-01-14 Sell Myles David C. Other officer 50,000 $28.87 $1.4M 2
2026-01-14 Sell Harmon Cyrus Director 3,489 $29.12 $101.6K 1
2026-01-13 Sell Myles David C. Other officer 50,000 $27.60 $1.4M 2
2026-01-13 Sell Kovacs Shane William Charles Other officer 3,822 $28.01 $107.1K 1
2026-01-12 Sell Myles David C. Other officer 10,000 $28.34 $283.4K 1
2025-12-23 Sell Zojwalla Naseem Other C-suite 99,509 $27.66 $2.8M 1
2025-12-22 Sell Zojwalla Naseem Other C-suite 100,000 $28.04 $2.8M 1
2025-12-22 Sell Harmon Cyrus Director 2,881 $28.53 $82.2K 1
2025-12-19 Sell CLARK IAN T Director 264,800 $29.73 $7.9M 3
2025-12-19 Sell Zojwalla Naseem Other C-suite 70,000 $28.20 $2.0M 2
2025-12-19 Sell Myles David C. Other officer 51,000 $30.46 $1.6M 3
2025-09-18 Sell Harmon Cyrus Director 13,086 $8.33 $109.0K 2
2025-09-16 Sell Harmon Cyrus Director 11,914 $8.05 $95.9K 2
2025-01-08 Buy Bain Capital Life Sciences Investors, LLC 10% owner 300,000 $5.76 $1.7M 1
2024-12-17 Sell Graham G. Walmsley Director 700,761 $6.75 $4.7M 1
2024-12-13 Sell Graham G. Walmsley Director 700,761 $6.75 $4.7M 1
2024-12-13 Buy Graham G. Walmsley Director 700,761 $6.75 $4.7M 1
2024-12-11 Sell Bohen Sean CEO 57,174 $8.68 $496.1K 2
2024-12-11 Sell Kovacs Shane William Charles Other officer 18,356 $8.68 $159.3K 2
2024-12-11 Sell Zojwalla Naseem Other C-suite 14,522 $8.68 $126.0K 2
2024-12-11 Sell Myles David C. Other officer 13,614 $8.68 $118.1K 2
2024-12-11 Sell Harmon Cyrus Director 8,137 $8.68 $70.6K 2
2024-12-10 Sell Bohen Sean CEO 52,328 $9.37 $490.3K 1
2024-12-10 Sell Kovacs Shane William Charles Other officer 16,803 $9.37 $157.4K 1
2024-12-10 Sell Zojwalla Naseem Other C-suite 13,283 $9.37 $124.5K 1
2024-12-10 Sell Myles David C. Other officer 12,452 $9.38 $116.8K 1
2024-12-10 Sell Harmon Cyrus Director 8,256 $9.37 $77.4K 1
2024-08-01 Sell Paradigm BioCapital International Fund Ltd. 10% owner 2,400,000 $14.92 $35.8M 2
2024-07-30 Sell Harmon Cyrus Director 934 $15.55 $14.5K 1
2024-07-29 Sell Harmon Cyrus Director 4,066 $15.58 $63.3K 1
2024-07-11 Sell Harmon Cyrus Director 5,000 $12.26 $61.3K 1
2024-06-28 Sell Harmon Cyrus Director 20,000 $10.77 $215.4K 1
2024-06-04 Sell Graham G. Walmsley Director 1,175,000 $14.85 $17.4M 2
2024-06-04 Sell Harmon Cyrus Director 5,000 $12.33 $61.6K 1
2024-06-03 Sell Harmon Cyrus Director 5,000 $10.93 $54.6K 1
2024-05-31 Sell Harmon Cyrus Director 15,000 $9.41 $141.2K 1
2024-05-06 Sell Harmon Cyrus Director 5,000 $10.92 $54.6K 1
2024-04-30 Sell Harmon Cyrus Director 15,000 $9.51 $142.6K 1
2024-03-28 Sell Harmon Cyrus Director 20,000 $10.97 $219.4K 1
2024-02-29 Sell Harmon Cyrus Director 25,000 $12.41 $310.3K 2
2024-02-01 Sell Harmon Cyrus Director 5,000 $15.56 $77.8K 1
2024-01-31 Sell Harmon Cyrus Director 25,000 $12.23 $305.8K 1
2023-12-29 Sell Harmon Cyrus Director 25,000 $13.38 $334.5K 2
2023-12-06 Buy Paradigm BioCapital International Fund Ltd. 10% owner 100,000 $11.60 $1.2M 1
2023-12-05 Buy Graham G. Walmsley Director 131,870 $14.19 $1.9M 3
2023-11-30 Sell Harmon Cyrus Director 25,000 $12.57 $314.2K 1
2023-11-22 Sell Bohen Sean CEO 27,932 $13.90 $388.3K 1
2023-11-22 Sell Kovacs Shane William Charles Other officer 9,145 $13.89 $127.0K 1
2023-11-22 Sell Zojwalla Naseem Other C-suite 7,095 $13.89 $98.5K 1
2023-11-22 Sell Myles David C. Other officer 6,653 $13.89 $92.4K 1
2023-11-22 Sell Harmon Cyrus Director 3,989 $13.90 $55.4K 1
2023-11-21 Sell Bohen Sean CEO 29,293 $14.88 $435.9K 2
2023-11-21 Sell Kovacs Shane William Charles Other officer 9,597 $14.86 $142.6K 2
2023-11-21 Sell Zojwalla Naseem Other C-suite 7,461 $14.84 $110.7K 2
2023-11-21 Sell Myles David C. Other officer 6,976 $14.88 $103.8K 2
2023-11-21 Sell Harmon Cyrus Director 4,192 $14.86 $62.3K 1
2023-11-08 Sell Myles David C. Other officer 200 $17.61 $3.5K 1
2023-11-03 Sell Myles David C. Other officer 541 $17.51 $9.5K 1
2023-11-02 Sell Harmon Cyrus Director 5,000 $15.64 $78.2K 1
2023-11-02 Sell Myles David C. Other officer 3,332 $15.36 $51.2K 1
2023-11-01 Sell Myles David C. Other officer 6,668 $15.02 $100.2K 1
2023-10-31 Sell Harmon Cyrus Director 25,000 $12.05 $301.2K 1
2023-09-29 Sell Harmon Cyrus Director 25,000 $12.41 $310.2K 1
2023-09-19 Sell Myles David C. Other officer 20,000 $12.67 $253.4K 1
2023-09-12 Buy LAMPERT MARK N Director 1,505,932 $9.84 $14.8M 3
2023-09-12 Buy Graham G. Walmsley Director 508,130 $9.84 $5.0M 1
2023-09-05 Sell Harmon Cyrus Director 10,000 $11.62 $116.2K 1
2023-08-31 Sell Harmon Cyrus Director 15,000 $9.36 $140.4K 1
2023-08-16 Sell Harmon Cyrus Director 15,000 $10.14 $152.1K 1
2023-06-08 Sell Harmon Cyrus Director 10,000 $6.30 $63.0K 1
2023-06-06 Sell Harmon Cyrus Director 5,000 $6.30 $31.5K 1
2023-06-05 Sell Harmon Cyrus Director 5,000 $6.05 $30.2K 1
2022-06-10 Buy LAMPERT MARK N Director 200,000 $4.03 $806.0K 2
2022-03-10 Sell Horn Kinney Other C-suite 5,253 $4.75 $25.0K 1
2022-01-10 Sell Horn Kinney Other C-suite 5,251 $6.85 $36.0K 1
2021-12-10 Sell Myles David C. Other C-suite 10,000 $10.30 $103.0K 1
2021-12-10 Sell Horn Kinney Other C-suite 5,251 $10.39 $54.6K 1
2021-11-30 Buy BVF PARTNERS L P/IL Director 739,675 $9.39 $6.9M 3
2021-11-29 Sell Harmon Cyrus Other C-suite 400 $24.76 $9.9K 1

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
Graham G. Walmsley Director $11.6M $26.9M 2024-12-17
Paradigm BioCapital International Fund Ltd. 10% owner $1.2M $35.8M 2024-08-01
LAMPERT MARK N Director $22.6M $0 2023-09-12
Zojwalla Naseem Other C-suite $0 $8.0M 2025-12-23
CLARK IAN T Director $0 $7.9M 2025-12-19
Myles David C. Other officer $0 $5.6M 2026-01-14
Harmon Cyrus Director $0 $4.8M 2026-07-24
Kovacs Shane William Charles Other officer $0 $3.6M 2026-01-15
Bohen Sean CEO $0 $1.8M 2024-12-11
Bain Capital Life Sciences Investors, LLC 10% owner $1.7M $0 2025-01-08
Mitchell Shawnte Other C-suite $0 $951.5K 2026-03-04
Horn Kinney Other C-suite $0 $115.5K 2022-03-10

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

Buying clusters at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2020-11-19 → 2020-11-23 3 $51.7M 44 -6.3% (-3.4% raw)-31.2% (-25.2% raw)-64.3% (-47.0% raw) closed

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.